Patented Lancet Technology Targeted In New Inter Partes Review Petition

(March 21, 2023, 10:37 AM EDT) -- ALEXANDRIA, Va. — In a March 20 petition for inter partes review (IPR), a medical diagnostic company focused on diabetes care seeks cancellation of 21 claims of a patent purportedly directed to improvements in lancet technology....

Attached Documents

Related Sections